Advertisement

Topics

Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

19:14 EST 9 Nov 2017 | News-Medical.net

Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod.

Original Article: Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

NEXT ARTICLE

More From BioPortfolio on "Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...